Platelet-activating factor-induced apoptosis is blocked by Bcl-2 in rat intestinal epithelial cells

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 286, Issue 2 49-2, 2004, Pages

  Lu, Jing ^a   Caplan, Michael S ^a   Saraf, Anita P ^a   Li, Dan ^a   Adler, Luba ^a   Liu, Xuesong ^a   Jilling, Tamas ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Bax; Caspase; DNA fragmentation; Inflammatory bowel diseases; Mitochondrial membrane potential; Necrotizing enterocolitis

Indexed keywords

5,5',6,6' TETRACHLORO 1,1',3,3' TETRAETHYLBENZIMIDAZOLYLCARBOCYANINE IODIDE; CARBOCYANINE; CASPASE 3; DNA FRAGMENT; GALACTOSIDE; ISOPROPYL BETA DEXTRO THIOGALACTOSIDE; PROTEIN BAX; PROTEIN BCL 2; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL MEMBRANE POTENTIAL; CONTROLLED STUDY; ENTERITIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM CELL; MITOCHONDRIAL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN LOCALIZATION; WESTERN BLOTTING;

EID: 1642498292     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00182.2003     Document Type: Article

References (51)

1. Adams JM and Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322-1326, 1998.
2. Alscher KT, Phang PT, McDonald TE, and Walley KR. Enteral feeding decreases gut apoptosis, permeability, and lung inflammation during murine endotoxemia. Am J Physiol Gastrointest Liver Physiol 281: G569-G576, 2001.
3. Barber LA, Spandau DF, Rathman SC, Murphy RC, Johnson CA, Kelley SW, Hurwitz SA, and Travers JB. Expression of the platelet-activating factor receptor results in enhanced ultraviolet B radiation-induced apoptosis in a human epidermal cell line. J Biol Chem 273: 18891-18897, 1998.
4. Benedetti A, Mancini R, Marucci L, Paolucci F, Jezequel AM, and Orlandi F. Quantitative study of apoptosis in normal rat gastroduodenal mucosa. J Gastroenterol Hepatol 5: 369-374, 1990.
5. Borner C. The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol Immunol 39: 615-647, 2003.
6. Braegger CP, Nicholls S, Murch SH, Stephens S, and MacDonald TT. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 339: 89-91, 1992.
7. Brichese L, Barboule N, Heliez C, and Valette A. Bcl-2 phosphorylation and proteasome-dependent degradation induced by paclitaxel treatment: consequences on sensitivity of isolated mitochondria to Bid. Exp Cell Res 278: 101-111, 2002.
8. Bronner MP, Culin C, Reed JC, and Furth EE. The bcl-2 protooncogene and the gastrointestinal epithelial tumor progression model. Am J Pathol 146: 20-26, 1995.
9. Caplan M, Hsueh W, Kelly A, and Donovan M. Serum PAF acetylhydrolase increases during neonatal maturation. Prostaglandins 39: 705-714, 1990.
10. Caplan MS, Hedlund E, Adler L, Lickerman M, and Hsueh W. The platelet-activating factor receptor antagonist WEB 2170 prevents neonatal necrotizing enterocolitis in rats. J Pediatr Gastroenterol Nutr 24: 296-301, 1997.
11. Caplan MS and Hsueh W. Necrotizing enterocolitis: role of platelet activating factor, endotoxin, and tumor necrosis factor. J Pediatr 117, 1990.
12. Caplan MS, Lickerman M, Adler L, Dietsch GN, and Yu A. The role of recombinant platelet-activating factor acetylhydrolase in a neonatal rat model of necrotizing enterocolitis. Pediatr Res 42: 779-783, 1997.
13. Chernavsky AC, Rubio AE, Vanzulli S, Rubinstein N, de Rosa S, and Fainboim L. Evidences of the involvement of Bak, a member of the Bcl-2 family of proteins, in active coeliac disease. Autoimmunity 35: 29-37, 2002.
14. Ciccocioppo R, D'Alo S, Di Sabatino A, Parroni R, Rossi M, Doglioni C, Cifone MG, and Corazza GR. Mechanisms of villous atrophy in autoimmune enteropathy and coeliac disease. Clin Exp Immunol 128: 88-93, 2002.
15. Claud EC, Li D, Xiao Y, Caplan MS, and Jilling T. Platelet-activating factor regulates chloride transport in intestinal epithelial cell monolayers. Pediatr Res 52: 155-62, 2002.
16. Coopersmith CM, O'Donnell D, and Gordon JI. Bcl-2 inhibits ischemia-reperfusion-induced apoptosis in the intestinal epithelium of transgenic mice. Am J Physiol Gastrointest Liver Physiol 276: G677-G686, 1999.
17. Ding J, Magnotti LJ, Huang Q, Xu DZ, Condon MR, and Deitch EA. Hypoxia combined with Escherichia coli produces irreversible gut mucosal injury characterized by increased intestinal cytokine production and DNA degradation. Shock 16: 189-195, 2001.
18. Eliakim R, Karmeli F, Razin E, and Rachmilewitz D. Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone. Gastroenterology 95: 1167-1172, 1988.
19. Ford H, Watkins S, Reblock K, and Rowe M. The role of inflammatory cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitis. J Pediatr Surg 32: 275-282, 1997.
20. Ford HR, Sorrells DL, and Knisely AS. Inflammatory cytokines, nitric oxide, and necrotizing enterocolitis. Semin Pediatr Surg 5: 155-159, 1996.
21. Gonzalez-Crussi F and Hsueh W. Experimental model of ischemic bowel necrosis. The role of platelet-activating factor and endotoxin. Am J Pathol 112: 127-135, 1983.
22. Hocke M, Richter L, Bosseckert H, and Eitner K. Platelet activating factor in stool from patients with ulcerative colitis and Crohn's disease. Hepatogastroenterology 46: 2333-2337, 1999.
23. Holt PR, Kotler DP, and Pascal RR. A simple method for determining epithelial cell turnover in small intestine. Studies in young and aging rat gut. Gastroenterology 84: 69-74, 1983.
24. Hostettler ME, Knapp PE, and Carlson SL. Platelet-activating factor induces cell death in cultured astrocytes and oligodendrocytes: involvement of caspase-3. Glia 38: 228-239, 2002.
25. Huang DC, Hahne M, Schroeter M, Frei K, Fontana A, Villunger A, Newton K, Tschopp J, and Strasser A. Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L). Proc Natl Acad Sci USA 96: 14871-14876, 1999.
26. Huigsloot M, Tijdens IB, Mulder GJ, and Van De Water B. Differential regulation of doxorubicin-induced mitochondrial dysfunction and apoptosis by Bcl-2 in mammary adenocarcinoma (MTLn3) cells. J Biol Chem 277: 35869-35879, 2002.
27. Ina K, Itoh J, Fukushima K, Kusugami K, Yamaguchi T, Kyokane K, Imada A, Binion DG, Musso A, West GA, Dobrea GM, McCormick TS, Lapetina EG, Levine AD, Ottaway CA, and Fiocchi C. Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance. J Immunol 163: 1081-1090, 1999.
28. Kald B, Smedh K, Olaison G, Sjodahl R, and Tagesson C. Platelet-activating factor acetylhydrolase activity in intestinal mucosa and plasma of patients with Crohn's disease. Digestion 57: 472-477, 1996.
29. Kitanaka C, Namiki T, Noguchi K, Mochizuki T, Kagaya S, Chi S, Hayashi A, Asai A, Tsujimoto Y, and Kuchino Y. Caspase-dependent apoptosis of COS-7 cells induced by Bax overexpression: differential effects of Bcl-2 and Bcl-xL on Bax-induced caspase activation and apoptosis. Oncogene 15: 1763-1772. 1997.
30. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, and Reed JC. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol 145: 1323-1336, 1994.
31. Krammer PH. CD95's deadly mission in the immune system. Nature 407: 789-795, 2000.
32. Levine AD and Fiocchi C. Regulation of life and death in lamina propria T cells. Semin Immunol 13: 195-199, 2001.
33. Lu L, Chaudhury P, and Osmond DG. Regulation of cell survival during B lymphopoiesis: apoptosis and Bcl-2/Bax content of precursor B cells in bone marrow of mice with altered expression of IL-7 and recombinase-activating gene-2. J Immunol 162: 1931-1940, 1999.
34. Merendino N, Dwinell MB, Varki N, Eckmann L, and Kagnoff MF. Human intestinal epithelial cells express receptors for platelet-activating factor. Am J Physiol Gastrointest Liver Physiol 277: G810-G818, 1999.
35. Merritt AJ, Potten CS, Watson AJ, Loh DY, Nakayama K, and Hickman JA. Differential expression of bcl-2 in intestinal epithelia. Correlation with attenuation of apoptosis in colonic crypts and the incidence of colonic neoplasia. J Cell Sci 108: 2261-2271, 1995.
36. Murphy KM, Streips UN, and Lock RB. Bcl-2 inhibits a Fas-induced conformational change in the Bax N terminus and Bax mitochondrial translocation. J Biol Chem 275: 17225-17228, 2000.
37. Novack DV and Korsmeyer SJ. Bcl-2 protein expression during murine development. Am J Pathol 145: 61-73, 1994.
38. Oltvai ZN, Milliman CL, and Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619, 1993.
39. Pritchard DM, Potten CS, Korsmeyer SJ, Roberts S, and Hickman JA. Damage-induced apoptosis in intestinal epithelia from bcl-2-null and bax-null mice: investigations of the mechanistic determinants of epithelial apoptosis in vivo. Oncogene 18: 7287-7293, 1999.
40. Rachmilewitz D, Karmeli F, and Eliakim R. Platelet-activating factor-a possible mediator in the pathogenesis of ulcerative colitis. Scand J Gastroenterol Suppl 172: 19-21, 1990.
41. Rosam AC, Wallace JL, and Whittle BJ. Potent ulcerogenic actions of platelet-activating factor on the stomach. Nature 319: 54-56, 1986.
42. Ruemmele FM, Beaulieu JF, Dionne S, Levy E, Seidman EG, Cerf-Bensussan N, and Lentze MJ. Lipopolysaccharide modulation of normal enterocyte turnover by toll-like receptors is mediated by endogenously produced tumour necrosis factor alpha. Gut 51: 842-848, 2002.
43. Shi LC, Wang HY, and Friedman E. Involvement of platelet-activating factor in cell death induced under ischemia/postischemia-like conditions in an immortalized hippocampal cell line. J Neurochem 70: 1035-1044, 1998.
44. Strater J, Wellisch I, Riedl S, Walczak H, Koretz K, Tandara A, Krammer PH, and Moller P. CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis. Gastroenterology 113: 160-167, 1997.
45. Tamaoki J, Sakai N, Isono K, Kanemura T, Yamawaki I, and Takizawa T. Effects of platelet-activating factor on bioelectric properties of cultured tracheal and bronchial epithelia. J Allergy Clin Immunol 87: 1042-1049, 1991.
46. Toledano BJ, Bastien Y, Noya F, Baruchel S, and Mazer B. Platelet-activating factor abrogates apoptosis induced by cross-linking of the surface IgM receptor in a human B lymphoblastoid cell line. J Immunol 158: 3705-3715, 1997.
47. Tsujimoto Y and Shimizu S. Bcl-2 family: life-or-death switch. FEBS Lett 466: 6-10, 2000.
48. Vachon PH, Cardin E, Harnois C, Reed JC, Plourde A, and Vezina A. Early acquisition of bowel segment-specific Bcl-2 homolog expression profiles during development of the human ileum and colon. Histol Histopathol 16: 497-510, 2001.
49. Von Reyher U, Strater J, Kittstein W, Gschwendt M, Krammer PH, and Moller P. Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis. Cancer Res 58: 526-534, 1998.
50. Wardle TD, Hall L, and Turnberg LA. Platelet activating factor: release from colonic mucosa in patients with ulcerative colitis and its effect on colonic secretion. Gut 38: 355-361, 1996.
51. Zhang H, Holzgreve W, and De Geyter C. Bcl2-L-10, a novel antiapoptotic member of the Bcl-2 family, blocks apoptosis in the mitochondria death pathway but not in the death receptor pathway. Hum Mol Genet 10: 2329-2339, 2001.